Pear Therapeutics, Inc. (CIK: 0001835567) EDGAR, Information, Filings... CompaniesBIO.Com

Pear Therapeutics, Inc.

Mailing address
200 STATE STREET, 13TH FLOOR, BOSTON, Delaware, 02109
Phone
6469322774
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
8000 - (CF Office: Office of Life Sciences) SERVICES-HEALTH SERVICES
Filings
N/A

Pear Therapeutics, Inc. (CIK: 0001835567) is an American company incorporated in the state of Massachusetts. Head office is located at 200 STATE STREET, 13TH FLOOR, BOSTON, Massachusetts, 02109. Work in the industry 8000 - (CF Office: Office of Life Sciences) SERVICES-HEALTH SERVICES. Pear Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Old names:

Thimble Point Acquisition Corp. from 2020-15-Dec to 2021-03-Dec

Owner	Filings	Transaction Date	Type of Owner
Wicks Timothy A	0001339919	Jun-14-2022	director
Rajaraman Shivakumar	0001849718	Jun-14-2022	director
Mango Paul	0001932759	Jun-14-2022	director
KLP SPAC 1 LLC	0001897847	Dec-06-2021	10 percent owner
Temasek Holdings (Private) Ltd	0001021944	Dec-03-2021	10 percent owner
ROCKLAGE SCOTT M	0001219014	Dec-03-2021	10 percent owner
GUIFFRE CHRISTOPHERD T	0001219021	Dec-03-2021	officer: CFO, COO, Treas., & Asst. Sec.
DIEKMAN JOHN D	0001240357	Dec-03-2021	10 percent owner
Christenson Michael J	0001319331	Dec-03-2021	other: See Remarks
Fitzgerald Meghan	0001349297	Dec-03-2021	other: See Remarks
SCHLICHTING NANCY M	0001376358	Dec-03-2021	director
Fullerton Management Pte Ltd	0001379348	Dec-03-2021	10 percent owner
Temasek Life Sciences Private Ltd	0001379349	Dec-03-2021	10 percent owner
Benson Steven J.	0001466391	Dec-03-2021	other: See Remarks
Miller Henry S	0001489216	Dec-03-2021	other: See Remarks
5AM Partners IV, LLC	0001589314	Dec-03-2021	10 percent owner
5AM Ventures IV, L.P.	0001589315	Dec-03-2021	10 percent owner
5AM Co-Investors IV, L.P.	0001593361	Dec-03-2021	10 percent owner
Bauerlein Alison	0001596080	Dec-03-2021	director
Schwab Andrew J.	0001598549	Dec-03-2021	director, 10 percent owner
Boms Elon	0001640948	Dec-03-2021	other: See Remarks
TLS Beta Pte. Ltd.	0001673754	Dec-03-2021	10 percent owner
Gomez Jorge M	0001726653	Dec-03-2021	director
5AM Opportunities I, L.P.	0001753000	Dec-03-2021	10 percent owner
Snow Ellen	0001786643	Dec-03-2021	officer: Chief Accounting Officer
5AM Opportunities I (GP), LLC	0001790778	Dec-03-2021	10 percent owner
LJ10 LLC	0001835571	Dec-03-2021	other: Former 10% Owner (see Remarks)
Iannotta Joseph	0001841400	Dec-03-2021	other: See Remarks
Brenner Erin K.	0001881042	Dec-03-2021	officer: Chief Product Dev. Officer
Jeffery Katherine	0001881043	Dec-03-2021	officer: Chief People Officer
Lynch Zack	0001881044	Dec-03-2021	director
Maricich Yuri	0001881045	Dec-03-2021	officer: Chief Medical Officer
McCann Corey	0001881049	Dec-03-2021	director, officer: President and CEO
O'Brien Ronan	0001881064	Dec-03-2021	officer: General Counsel & Secretary
Reddy Kirthiga	0001881139	Dec-03-2021	director
Strandberg Julia	0001881152	Dec-03-2021	officer: Chief Commercial Officer
Elbrus Investments Pte. Ltd.	0001896264	Dec-03-2021	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pear Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
25-NSE	Document	Acc-no: 0001354457-23-000332 (34 Act) Size: 3 KB	May-02-2023	001-39969
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-23-052929 (34 Act) Size: 89 KB	Apr-28-2023	005-92635 23866009
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-024105 ( Act) Size: 20 KB	Apr-12-2023
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001104659-23-044618 (34 Act) Size: 144 KB	Apr-12-2023	005-92635 23816074
8-K	Document	Current report filing Acc-no: 0001835567-23-000022 (34 Act) Size: 1687 KB	Apr-10-2023	001-39969 23811527
8-K	Document	Current report filing Acc-no: 0001835567-23-000020 (34 Act) Size: 1742 KB	Apr-07-2023	001-39969 23808153
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001835567-23-000018 (34 Act) Size: 14526 KB	Mar-31-2023	001-39969 23787353
8-K	Document	Current report filing Acc-no: 0001835567-23-000014 (34 Act) Size: 1715 KB	Mar-17-2023	001-39969 23740848
8-K	Document	Current report filing Acc-no: 0001835567-23-000010 (34 Act) Size: 1704 KB	Feb-24-2023	001-39969 23666988
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004045 ( Act) Size: 7 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004044 ( Act) Size: 5 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004043 ( Act) Size: 5 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004042 ( Act) Size: 5 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004041 ( Act) Size: 5 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004040 ( Act) Size: 5 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004039 ( Act) Size: 5 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004037 ( Act) Size: 4 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004036 ( Act) Size: 4 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004034 ( Act) Size: 4 KB	Feb-17-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001062993-23-004032 ( Act) Size: 4 KB	Feb-17-2023

Recent 20 filings. View all Pear Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Pear Therapeutics, Inc. overview
Pear Therapeutics, Inc. job
Pear Therapeutics, Inc. stock
Pear Therapeutics, Inc. ownership
Pear Therapeutics, Inc. CEO
Pear Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.